The Calmer Co International (ASX:CCO) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


What is The Calmer Co International Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

The Calmer Co International's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ASX:CCO vs KHC, GIS: Margin of Safety % (DCF FCF Based) Comparison

For the Packaged Foods subindustry, The Calmer Co International's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Calmer Co International Margin of Safety % (DCF FCF Based) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, The Calmer Co International's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where The Calmer Co International's Margin of Safety % (DCF FCF Based) falls into.


The Calmer Co International Business Description

Address 96 Victoria Street, West End, Brisbane, QLD, AUS, 4101
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji, and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are: Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading), which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji and other regions.